| Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers KB Kuchenbaecker, JL Hopper, DR Barnes, KA Phillips, TM Mooij, ... Jama 317 (23), 2402-2416, 2017 | 2678 | 2017 |
| Association analysis identifies 65 new breast cancer risk loci K Michailidou, S Lindström, J Dennis, J Beesley, S Hui, S Kar, A Lemaçon, ... Nature 551 (7678), 92-94, 2017 | 1305 | 2017 |
| Large-scale genotyping identifies 41 new loci associated with breast cancer risk K Michailidou, P Hall, A Gonzalez-Neira, M Ghoussaini, J Dennis, ... Nature genetics 45 (4), 353-361, 2013 | 1258 | 2013 |
| The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds 12(3): 333-7. Nat Genet 12 (3), 333-337, 1996 | 1149 | 1996 |
| Is dehydroepiandrosterone a hormone? F Labrie, A Belanger, SX Lin, J Simard, G Pelletier, C Labrie Journal of Endocrinology 187 (2), 169-196, 2005 | 909 | 2005 |
| Polygenic risk scores for prediction of breast cancer and breast cancer subtypes N Mavaddat, K Michailidou, J Dennis, M Lush, L Fachal, A Lee, JP Tyrer, ... The American Journal of Human Genetics 104 (1), 21-34, 2019 | 894 | 2019 |
| Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) N Mavaddat, D Barrowdale, IL Andrulis, SM Domchek, D Eccles, ... Cancer Epidemiology, Biomarkers & Prevention 21 (1), 134-147, 2012 | 755 | 2012 |
| A candidate prostate cancer susceptibility gene at chromosome 17p SV Tavtigian, J Simard, DHF Teng, V Abtin, M Baumgard, A Beck, ... Nature genetics 27 (2), 172-180, 2001 | 723 | 2001 |
| Prediction of breast cancer risk based on profiling with common genetic variants N Mavaddat, PDP Pharoah, K Michailidou, J Tyrer, MN Brook, MK Bolla, ... Journal of the National Cancer Institute 107 (5), djv036, 2015 | 668 | 2015 |
| Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer K Michailidou, J Beesley, S Lindstrom, S Canisius, J Dennis, MJ Lush, ... Nature genetics 47 (4), 373-380, 2015 | 649 | 2015 |
| Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ... Nature genetics 45 (4), 371-384, 2013 | 645 | 2013 |
| Molecular Biology of the 3β-Hydroxysteroid Dehydrogenase/Δ5-Δ4 Isomerase Gene Family J Simard, ML Ricketts, S Gingras, P Soucy, FA Feltus, MH Melner Endocrine reviews 26 (4), 525-582, 2005 | 640 | 2005 |
| Breast cancer risk genes—association analysis in more than 113,000 women Breast Cancer Association Consortium New England Journal of Medicine 384 (5), 428-439, 2021 | 606 | 2021 |
| A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: implications for presymptomatic testing and screening D Shattuck-Eidens, M McClure, J Simard, F Labrie, S Narod, F Couch, ... Jama 273 (7), 535-541, 1995 | 596 | 1995 |
| BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors A Lee, N Mavaddat, AN Wilcox, AP Cunningham, T Carver, S Hartley, ... Genetics in medicine 21 (8), 1708-1718, 2019 | 560 | 2019 |
| Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone F Labrie, V Luu-The, C Labrie, A Bélanger, J Simard, SX Lin, G Pelletier Endocrine reviews 24 (2), 152-182, 2003 | 552 | 2003 |
| Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ... Jama 313 (13), 1347-1361, 2015 | 545 | 2015 |
| The key role of 17β-hydroxysteroid dehydrogenases in sex steroid biology F Labrie, V Luu-The, SX Lin, L Claude, J Simard, R Breton, A Bélanger Steroids 62 (1), 148-158, 1997 | 514 | 1997 |
| Genome-wide association studies identify four ER negative–specific breast cancer risk loci M Garcia-Closas, FJ Couch, S Lindstrom, K Michailidou, MK Schmidt, ... Nature genetics 45 (4), 392-398, 2013 | 471 | 2013 |
| BRCA2 germline mutations in male breast cancer cases and breast cancer families FJ Couch, LM Farid, ML DeShano, SV Tavtigian, K Calzone, L Campeau, ... Nature genetics 13 (1), 123-125, 1996 | 442 | 1996 |
Douglas EastonProfessor of Genetic Epidemiology, University of CambridgeBestätigte E-Mail-Adresse bei medschl.cam.ac.uk
